Soteri Polydorou1, Stephen Ross1, Peter Coleman1, Laura Duncan1, Nichole Roxas1, Anil Thomas1, Sonia Mendoza1, Helena Hansen1. 1. Dr. Polydorou, Dr. Ross, Dr. Thomas, and Dr. Hansen are with the Department of Psychiatry, where Ms. Duncan was affiliated at the time of this study, Dr. Polydorou is also with the Department of Medicine, Dr. Hansen is also with the Nathan S. Kline Institute for Psychiatric Research, and Ms. Mendoza is with the Department of Psychiatry and Anthropology, where Ms. Roxas was affiliated at the time of this study, all at New York University, New York (e-mail: soteri.polydorou@nyumc.org ). Ms. Duncan is currently a medical student at the University of California San Francisco. Ms. Mendoza is currently a doctoral student at the Columbia University Mailman School of Public Health, New York. Ms. Roxas is currently a medical student at the University of Rochester School of Medicine and Dentistry, Rochester, New York. Mr. Coleman, who is retired, was with the Office of Behavioral Health, New York City Health and Hospitals, New York, at the time of this study.
Abstract
OBJECTIVES: This report identifies the institutional barriers to, and benefits of, buprenorphine maintenance treatment (BMT) integration in an established hospital-based opioid treatment program (OTP). METHODS: This case study presents the authors' experiences at the clinic, hospital, and corporation levels during efforts to integrate BMT into a hospital-based OTP in New York City and a descriptive quantitative analysis of the characteristics of hospital outpatients treated with buprenorphine from 2006 to 2013 (N=735). RESULTS: Integration of BMT into an OTP offered patients the flexibility to transition between intensive structured care and primary care or outpatient psychiatry according to need. Main barriers encountered were regulations, clinical logistics of dispensing medications, internal cost and reimbursement issues, and professional and cultural resistance. CONCLUSIONS: Buprenorphine integration offers a model for other OTPs to facilitate partnerships among primary care and mental health clinics to better serve diverse patients with varying clinical needs and with varying levels of social support.
OBJECTIVES: This report identifies the institutional barriers to, and benefits of, buprenorphine maintenance treatment (BMT) integration in an established hospital-based opioid treatment program (OTP). METHODS: This case study presents the authors' experiences at the clinic, hospital, and corporation levels during efforts to integrate BMT into a hospital-based OTP in New York City and a descriptive quantitative analysis of the characteristics of hospital outpatients treated with buprenorphine from 2006 to 2013 (N=735). RESULTS: Integration of BMT into an OTP offered patients the flexibility to transition between intensive structured care and primary care or outpatient psychiatry according to need. Main barriers encountered were regulations, clinical logistics of dispensing medications, internal cost and reimbursement issues, and professional and cultural resistance. CONCLUSIONS:Buprenorphine integration offers a model for other OTPs to facilitate partnerships among primary care and mental health clinics to better serve diverse patients with varying clinical needs and with varying levels of social support.
Entities:
Keywords:
Buprenorphine treatment; Drug abuse; Opioid treatment program; methadone treatment
Authors: Joshua D Lee; Ellie Grossman; Andrea Truncali; John Rotrosen; Andrew Rosenblum; Stephen Magura; Marc N Gourevitch Journal: Subst Abus Date: 2012 Impact factor: 3.716
Authors: Brent A Moore; Declan T Barry; Lynn E Sullivan; Patrick G Oʼconnor; Christopher J Cutter; Richard S Schottenfeld; David A Fiellin Journal: J Addict Med Date: 2012-09 Impact factor: 3.702
Authors: Babak Tofighi; Ellie Grossman; Emily Buirkle; Jennifer McNeely; Marc Gourevitch; Joshua D Lee Journal: J Addict Med Date: 2015 May-Jun Impact factor: 3.702
Authors: Helena B Hansen; Carole E Siegel; Brady G Case; David N Bertollo; Danae DiRocco; Marc Galanter Journal: J Behav Health Serv Res Date: 2013-07 Impact factor: 1.505
Authors: Jennifer McNeely; Marc N Gourevitch; Denise Paone; Sharmila Shah; Shana Wright; Daliah Heller Journal: BMC Public Health Date: 2012-06-18 Impact factor: 3.295
Authors: Gwen Lapham; Denise M Boudreau; Eric A Johnson; Jennifer F Bobb; Abigail G Matthews; Jennifer McCormack; David Liu; Jeffrey H Samet; Andrew J Saxon; Cynthia I Campbell; Joseph E Glass; Rebecca C Rossom; Mark T Murphy; Ingrid A Binswanger; Bobbi Jo H Yarborough; Katharine A Bradley Journal: Drug Alcohol Depend Date: 2019-11-15 Impact factor: 4.492